Latest Ratios: P/E Ratio -14.7x · EV/EBITDA N/A · ROE -17.2%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.7B | $2.8B | $2.0B | $1.4B | $710M | $1.1B | $3.1B | — | — |
| Enterprise Value | $1.4B | $2.6B | $1.9B | $1.3B | $609M | $925M | $3.2B | — | — |
| P/E Ratio → | -14.70 | — | — | — | — | — | — | — | — |
| P/S Ratio | 2.49 | 4.19 | 3.89 | 3.38 | 2.08 | 4.37 | 20.98 | — | — |
| P/B Ratio | 2.28 | 3.88 | 3.47 | 2.44 | 1.23 | 1.62 | 14.87 | — | — |
| P/FCF | 25.82 | 43.50 | 112.77 | — | — | — | — | — | — |
| P/OCF | 19.29 | 32.50 | 24.25 | 93.84 | — | — | 184.00 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.82 | 3.68 | 3.17 | 1.78 | 3.52 | 21.52 | — | — |
| EV / EBITDA | — | — | 134.13 | 415.98 | — | — | 230.10 | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | 39.62 | 106.93 | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.0% | 23.0% | 25.2% | 16.7% | 0.8% | -81.2% | 23.8% | 22.1% | 40.9% |
| Operating Margin | -15.6% | -15.6% | -11.5% | -18.0% | -53.6% | -218.2% | -14.0% | -31.6% | -19.7% |
| Net Profit Margin | -16.7% | -16.7% | -12.3% | -20.7% | -53.3% | -225.6% | -20.3% | -35.1% | -28.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -17.2% | -17.2% | -11.0% | -14.9% | -28.3% | -129.2% | -46.7% | -44.7% | -9.7% |
| ROA | -11.6% | -11.6% | -8.0% | -11.0% | -21.9% | -92.8% | -7.9% | -10.9% | -7.0% |
| ROIC | -16.6% | -16.6% | -9.2% | -11.6% | -28.6% | -110.8% | -11.4% | -19.1% | -4.3% |
| ROCE | -15.3% | -15.3% | -9.9% | -12.4% | -27.4% | -110.3% | -6.7% | -11.0% | -5.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.01 | 0.03 | 0.04 | 0.00 | 0.44 | — | 0.24 |
| Debt / EBITDA | — | — | 0.54 | 4.67 | — | — | 6.64 | — | 996.21 |
| Net Debt / Equity | — | -0.35 | -0.18 | -0.15 | -0.18 | -0.31 | 0.38 | — | 0.15 |
| Net Debt / EBITDA | — | — | -7.32 | -27.18 | — | — | 5.80 | — | 617.86 |
| Debt / FCF | — | -3.87 | -5.83 | — | — | — | — | — | 5.55 |
| Interest Coverage | -17432.17 | -17432.17 | — | — | -121.86 | -180.46 | -2.62 | -5.14 | — |
Net cash position: cash ($281M) exceeds total debt ($30M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.56 | 1.56 | 1.43 | 1.34 | 1.38 | 2.12 | 0.72 | 0.71 | 1.67 |
| Quick Ratio | 1.56 | 1.56 | 1.43 | 1.34 | 1.38 | 2.12 | 0.71 | 0.70 | 1.66 |
| Cash Ratio | 0.80 | 0.80 | 0.55 | 0.55 | 0.72 | 1.46 | 0.14 | 0.15 | 0.95 |
| Asset Turnover | — | 0.59 | 0.64 | 0.53 | 0.44 | 0.30 | 0.38 | 0.31 | 0.24 |
| Inventory Turnover | 1815.66 | 1815.66 | 792.92 | 991.27 | 1194.93 | 898.43 | 297.05 | 317.83 | 325.82 |
| Days Sales Outstanding | — | 102.33 | 88.90 | 103.29 | 78.36 | 107.44 | 84.98 | 86.06 | 57.58 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | 27.3% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | 3.9% | 2.3% | 0.9% | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 27.3% | 0.0% | — | — |
| Shares Outstanding | — | $255M | $230M | $226M | $199M | $151M | $179M | $179M | $261M |
Escalating Rights Cost Pressure
Based on current market data, GENI trades at a price-to-sales ratio of 2.38, which appears to price in aggressive top-line expansion while ignoring the lack of GAAP profitability, a valuation stance that warrants caution when compared to the more established, albeit slower-growing, industry peers.
The negative P/E ratio of -14.09 highlights that investors are currently valuing the company purely on its revenue growth trajectory rather than its ability to generate bottom-line earnings. This valuation approach assumes that the company will eventually achieve significant operating leverage, yet the current P/S multiple suggests the market remains skeptical of the timeline for that transition.
As reported in recent financial statements, GENI's ROIC of -4.4% in 2026Q1 underscores a persistent inability to generate returns on invested capital that exceed the cost of funding, a trend that has remained stubbornly negative throughout the last ten quarters of aggressive rights acquisition.
The consistent decay in ROIC suggests that the capital deployed to secure exclusive data rights is not yet yielding sufficient incremental revenue to justify the investment. Investors should monitor whether the company can improve its capital efficiency as it shifts toward higher-margin streaming products, or if the current model is structurally incapable of generating positive economic value.
According to quarterly filings, the company's cash conversion cycle reached 33 days in 2026Q1, reflecting a reliance on extended payment terms from sportsbook clients that complicates the firm's ability to manage the heavy, fixed-cost obligations inherent in its exclusive league data rights agreements.
The DSO of 87 days suggests that the company is effectively financing its sportsbook clients, which creates a mismatch between the timing of cash inflows and the rigid, non-cancellable payments owed to sports leagues. This working capital inefficiency appears to be a structural feature of the business model that limits liquidity during off-peak sporting seasons.
Based on the latest financial data, the current ratio of 1.59 provides a buffer for short-term obligations, yet the rapid decline in cash from 2025Q4 to 2026Q1 highlights a vulnerability to the seasonal cash outflows that characterize the company's rights-heavy operating model.
While the current ratio appears adequate on the surface, it masks the underlying volatility of cash flows that are heavily dependent on the global sports calendar. The company's liquidity position may be more fragile than the headline ratio suggests, particularly if the timing of league payments does not align perfectly with the receipt of sportsbook revenue shares.
The most commonly misapplied metric for GENI is Adjusted EBITDA, which frequently obscures the company's true cash-generating potential by excluding significant stock-based compensation and the amortization of capitalized data rights that are essential to maintaining the firm's competitive position in the sports betting market.
Investors should instead focus on free cash flow and the 'rights value utilization' ratio to better understand the company's underlying performance. Relying on EBITDA allows the company to present a more favorable picture of profitability that ignores the reality of the massive, recurring cash outflows required to secure the exclusive data rights that underpin the entire business.
Includes 30+ ratios · 8 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GENI stock.
Genius Sports Limited's current P/E ratio is -14.7x. This places it at the 50th percentile of its historical range.
Genius Sports Limited's return on equity (ROE) is -17.2%. The historical average is -37.7%.
Based on historical data, Genius Sports Limited is trading at a P/E of -14.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Genius Sports Limited has 23.0% gross margin and -15.6% operating margin.